Cargando…

Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk

INTRODUCTION: We compared retinal layers’ thickness between apolipoprotein E (APOE) Ɛ4 carriers and non‐carriers in a cohort of cognitively normal middle‐aged adults enriched for Alzheimer's disease (AD) risk. METHODS: Participants (N = 245) underwent spectral domain optical coherence tomograph...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotenstreich, Ygal, Sharvit‐Ginon, Inbal, Sher, Ifat, Zloto, Ofira, Fabian, Ido Didi, Abd‐Elkader, Amir, Weller, Aron, Heymann, Anthony, Beeri, Michal Schnaider, Ravona‐Springer, Ramit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828987/
https://www.ncbi.nlm.nih.gov/pubmed/35155732
http://dx.doi.org/10.1002/dad2.12275
_version_ 1784647966302142464
author Rotenstreich, Ygal
Sharvit‐Ginon, Inbal
Sher, Ifat
Zloto, Ofira
Fabian, Ido Didi
Abd‐Elkader, Amir
Weller, Aron
Heymann, Anthony
Beeri, Michal Schnaider
Ravona‐Springer, Ramit
author_facet Rotenstreich, Ygal
Sharvit‐Ginon, Inbal
Sher, Ifat
Zloto, Ofira
Fabian, Ido Didi
Abd‐Elkader, Amir
Weller, Aron
Heymann, Anthony
Beeri, Michal Schnaider
Ravona‐Springer, Ramit
author_sort Rotenstreich, Ygal
collection PubMed
description INTRODUCTION: We compared retinal layers’ thickness between apolipoprotein E (APOE) Ɛ4 carriers and non‐carriers in a cohort of cognitively normal middle‐aged adults enriched for Alzheimer's disease (AD) risk. METHODS: Participants (N = 245) underwent spectral domain optical coherence tomography. Multivariate analyses of covariance adjusting for age, sex, education, and best corrected vision acuity was used to compare retinal thickness between APOE groups. RESULTS: Participants’ mean age was 59.60 (standard deviation = 6.42) with 66.4% women and 32.2% APOE Ɛ4 carriers. Greater macular full thickness was observed in APOE Ɛ4 carriers compared to non‐carriers (P = .017), reaching statistical significance for the inner and outer nasal (P = .009 and P = .005, respectively), inner superior (P = .041), and inner and outer inferior (P = .013 and P = .033, respectively) sectors. The differences between APOE groups were mainly driven by the ganglion cell layer (P < .05) and the inner plexiform layer (P < .05). DISCUSSION: A thicker macula is observed already in midlife asymptomatic APOE Ɛ4 carriers at high AD risk.
format Online
Article
Text
id pubmed-8828987
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88289872022-02-11 Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk Rotenstreich, Ygal Sharvit‐Ginon, Inbal Sher, Ifat Zloto, Ofira Fabian, Ido Didi Abd‐Elkader, Amir Weller, Aron Heymann, Anthony Beeri, Michal Schnaider Ravona‐Springer, Ramit Alzheimers Dement (Amst) Retinal Imaging INTRODUCTION: We compared retinal layers’ thickness between apolipoprotein E (APOE) Ɛ4 carriers and non‐carriers in a cohort of cognitively normal middle‐aged adults enriched for Alzheimer's disease (AD) risk. METHODS: Participants (N = 245) underwent spectral domain optical coherence tomography. Multivariate analyses of covariance adjusting for age, sex, education, and best corrected vision acuity was used to compare retinal thickness between APOE groups. RESULTS: Participants’ mean age was 59.60 (standard deviation = 6.42) with 66.4% women and 32.2% APOE Ɛ4 carriers. Greater macular full thickness was observed in APOE Ɛ4 carriers compared to non‐carriers (P = .017), reaching statistical significance for the inner and outer nasal (P = .009 and P = .005, respectively), inner superior (P = .041), and inner and outer inferior (P = .013 and P = .033, respectively) sectors. The differences between APOE groups were mainly driven by the ganglion cell layer (P < .05) and the inner plexiform layer (P < .05). DISCUSSION: A thicker macula is observed already in midlife asymptomatic APOE Ɛ4 carriers at high AD risk. John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC8828987/ /pubmed/35155732 http://dx.doi.org/10.1002/dad2.12275 Text en © 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Retinal Imaging
Rotenstreich, Ygal
Sharvit‐Ginon, Inbal
Sher, Ifat
Zloto, Ofira
Fabian, Ido Didi
Abd‐Elkader, Amir
Weller, Aron
Heymann, Anthony
Beeri, Michal Schnaider
Ravona‐Springer, Ramit
Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title_full Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title_fullStr Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title_full_unstemmed Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title_short Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD risk
title_sort thicker macula in asymptomatic apoe ɛ4 middle‐aged adults at high ad risk
topic Retinal Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828987/
https://www.ncbi.nlm.nih.gov/pubmed/35155732
http://dx.doi.org/10.1002/dad2.12275
work_keys_str_mv AT rotenstreichygal thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT sharvitginoninbal thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT sherifat thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT zlotoofira thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT fabianidodidi thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT abdelkaderamir thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT welleraron thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT heymannanthony thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT beerimichalschnaider thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk
AT ravonaspringerramit thickermaculainasymptomaticapoeɛ4middleagedadultsathighadrisk